BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 9295239)

  • 1. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.
    Whalen CC; Johnson JL; Okwera A; Hom DL; Huebner R; Mugyenyi P; Mugerwa RD; Ellner JJ
    N Engl J Med; 1997 Sep; 337(12):801-8. PubMed ID: 9295239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
    Gordin F; Chaisson RE; Matts JP; Miller C; de Lourdes Garcia M; Hafner R; Valdespino JL; Coberly J; Schechter M; Klukowicz AJ; Barry MA; O'Brien RJ
    JAMA; 2000 Mar; 283(11):1445-50. PubMed ID: 10732934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.
    Johnson JL; Okwera A; Hom DL; Mayanja H; Mutuluuza Kityo C; Nsubuga P; Nakibali JG; Loughlin AM; Yun H; Mugyenyi PN; Vernon A; Mugerwa RD; Ellner JJ; Whalen CC;
    AIDS; 2001 Nov; 15(16):2137-47. PubMed ID: 11684933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
    Halsey NA; Coberly JS; Desormeaux J; Losikoff P; Atkinson J; Moulton LH; Contave M; Johnson M; Davis H; Geiter L; Johnson E; Huebner R; Boulos R; Chaisson RE
    Lancet; 1998 Mar; 351(9105):786-92. PubMed ID: 9519950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.
    Mwinga A; Hosp M; Godfrey-Faussett P; Quigley M; Mwaba P; Mugala BN; Nyirenda O; Luo N; Pobee J; Elliott AM; McAdam KP; Porter JD
    AIDS; 1998 Dec; 12(18):2447-57. PubMed ID: 9875583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration.
    Whalen C; Okwera A; Johnson J; Vjecha M; Hom D; Wallis R; Huebner R; Mugerwa R; Ellner J
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1977-81. PubMed ID: 8665064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tuberculosis preventive therapy on HIV disease progression and survival in HIV-infected adults.
    Lim HJ; Okwera A; Mayanja-Kizza H; Ellner JJ; Mugerwa RD; Whalen CC
    HIV Clin Trials; 2006; 7(4):172-83. PubMed ID: 17065029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost-effectiveness analysis.
    Rose DN
    Ann Intern Med; 1998 Nov; 129(10):779-86. PubMed ID: 9841583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.
    Gordin FM; Matts JP; Miller C; Brown LS; Hafner R; John SL; Klein M; Vaughn A; Besch CL; Perez G; Szabo S; El-Sadr W
    N Engl J Med; 1997 Jul; 337(5):315-20. PubMed ID: 9233868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New regimens to prevent tuberculosis in adults with HIV infection.
    Martinson NA; Barnes GL; Moulton LH; Msandiwa R; Hausler H; Ram M; McIntyre JA; Gray GE; Chaisson RE
    N Engl J Med; 2011 Jul; 365(1):11-20. PubMed ID: 21732833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.
    Hawken MP; Meme HK; Elliott LC; Chakaya JM; Morris JS; Githui WA; Juma ES; Odhiambo JA; Thiong'o LN; Kimari JN; Ngugi EN; Bwayo JJ; Gilks CF; Plummer FA; Porter JD; Nunn PP; McAdam KP
    AIDS; 1997 Jun; 11(7):875-82. PubMed ID: 9189212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Randomized trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy].
    Rivero A; López-Cortés L; Castillo R; Lozano F; García MA; Díez F; Escribano JC; Canueto J; Pasquau J; Hernández JJ; Polo R; Martínez-Marcos FJ; Kindelán JM; Rey R;
    Enferm Infecc Microbiol Clin; 2003; 21(6):287-92. PubMed ID: 12809582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of latent tuberculosis infection in HIV infected persons.
    Akolo C; Adetifa I; Shepperd S; Volmink J
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD000171. PubMed ID: 20091503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.
    Rangaka MX; Wilkinson RJ; Boulle A; Glynn JR; Fielding K; van Cutsem G; Wilkinson KA; Goliath R; Mathee S; Goemaere E; Maartens G
    Lancet; 2014 Aug; 384(9944):682-90. PubMed ID: 24835842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration.
    Okwera A; Whalen C; Byekwaso F; Vjecha M; Johnson J; Huebner R; Mugerwa R; Ellner J
    Lancet; 1994 Nov; 344(8933):1323-8. PubMed ID: 7526098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for preventing tuberculosis in HIV infected persons.
    Wilkinson D
    Cochrane Database Syst Rev; 2000; (2):CD000171. PubMed ID: 10796501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.